ARCHIVES

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

This article is from The Cancer Letter archive.

Vol. 23 No. 7 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 7 Issue 4, Assembly Edition 1993

September 13, 1993

Provenge Met Criteria For Approval, Sponsor Says

May 1, 2009

NCI Fund Grants To Increase Minority Internet Access.

October 6, 2000

LAK –IL-2 Studies Continue, Moertel Editorial Blasted

March 13, 1987

AACR Academy Names 2014 Class of Fellows

April 4, 2014

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009